Not Yet RecruitingNot Applicable

Reconstruction of Diffusely Diseased Left Anterior Descending with Left Internal Mammary Artery On-lay Patch or Saphenous Vein Patch Without Endarterectomy by Opening the Whole Wall of the Diseased Segment(s) Has Less Risk and Fewer Complications Compared to Endarterectomy Technique

90 participantsStarted 2025-12-10

Plain-language summary

The objective of this study is to compare different surgical strategies for management of severely diseased LAD artery during CABG i.e. LIMA on-lay patch vs. saphenous vein patch and the distal in situ LIMA and saphenous vein graft (LIMA+ SVG).

Who can participate

Age range15 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * included patients with long-segment diffusely diseased LAD, with good ejection fraction and elective surgery. Exclusion Criteria: * Patients with associated valve surgery, left ventricular EF less than 40%, and severe comorbidities (renal or liver failure), preoperative dialysis, and hemodynamic instability, emergency operations were excluded.

What they're measuring

Serum troponin level

Timeframe: From enrollment to 1 month after intervention

Trial details

NCT IDNCT06835114

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-10

Contact for this trial

Ahmed Ibrahim Gadallah

+201067172284 ahmedgadallah629@gmail.com

View on ClinicalTrials.gov More LAD (Left Anterior Descending) Coronary Artery Stenosis trials